Medical science has long recognized the empirical truth that physical activity builds resilient bones, yet the precise biochemical mechanisms governing…
Read More
Sling Therapeutics Secures $123M in Series C Financing to Advance Pivotal Phase III Trial of First-in-Class Oral TED Treatment
Sling Therapeutics has closed a significant $123 million Series C financing round, directing the capital toward the pivotal late-stage clinical…
Read More
The Paradigm Shift in Healthcare: How Cell and Gene Therapies Are Redefining the Treatment of Rare Diseases
Rare diseases have long presented one of the most stubborn and heartbreaking frontiers in modern medicine. Historically characterized by profound…
Read More
New injectable treatment helps the brain rebuild after stroke
For decades, the standard of care for ischemic strokes has been limited to time-sensitive interventions. When a blood clot blocks…
Read More
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Researchers at King’s College London have identified a promising new therapeutic strategy for Alzheimer’s disease by targeting several of the…
Read More
Yale Researchers Uncover Molecular Mechanism Behind Anti-Sperm Antibodies Providing New Pathways for Infertility Treatment and Male Contraception
A multidisciplinary research team led by Yale University has successfully mapped the molecular architecture of a naturally occurring biological mechanism…
Read More
New Therapies Usher in Era of Personalised Treatment for Rare Blood Cancers
A significant advancement in the treatment of rare blood cancers is set to transform the lives of approximately 200 patients…
Read More
Johnson & Johnson’s Spravato Remission Data Takes Center Stage in Push for Treatment-Resistant Depression Growth
A recent poster presentation at Psych Congress Elevate by Johnson & Johnson has placed esketamine nasal spray, marketed as Spravato,…
Read More
Novartis Fabhalta Receives Traditional FDA Approval for IgAN Treatment
The U.S. Food and Drug Administration (FDA) has granted traditional approval to Novartis for Fabhalta (iptacopan), a groundbreaking oral Factor…
Read More
Discovery of Fam102a as a Dual Regulator in Bone Remodeling Offers New Pathway for Osteoporosis Treatment
The landscape of regenerative medicine and endocrinology has shifted following the landmark identification of a novel protein that serves as…
Read More
